title: [Surgical treatment modalities in uveal melanomas].
abstract: The treatment of large uveal melanomas poses a therapeutic challenge, due to the expected treatment-related side-effects. After sole radiotherapy the majority of patients are faced with radiogenic complications secondary to the large amount of tumour necrosis. Alternative treatment modalities addressing this issue are transscleral resection in arterial hypotension in anteriorly located tumours and endoresection via pars plana vitrectomy in posteriorly located tumours. A surgical resection treatment was applied in 292 patients with large uveal melanomas. In 150 patients the tumour was treated by transscleral resection and postoperative adjuvant (106)ruthenium brachytherapy and 142 patients were treated by primary proton beam irradiation and secondary endoresection. The mean follow-up time was 3.8 and 2.5 years, respectively. Local tumour control was achieved in 76 % and 98 %, respectively. The 5-year metastatic rates were 28 % and 21 % and eye retention was achieved in 82 % and 97 %, respectively. Surgical resection of uveal melanomas with adjuvant radiotherapy is the treatment of choice in cases of large tumours, avoiding enucleation in the vast majority of cases in the long term, without increasing the incidence of tumour-related risks.
authors.affiliation: Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Innsbruck, Anichstrasse 35, Innsbruck, Austria. nikolaos.bechrakis@i-med.ac.at
authors.forename: N E
authors.initials: NE
authors.lastname: Bechrakis
authors.forename: V
authors.initials: V
authors.lastname: Petousis
authors.forename: L
authors.initials: L
authors.lastname: Krause
authors.forename: J
authors.initials: J
authors.lastname: Wachtlin
authors.forename: G
authors.initials: G
authors.lastname: Willerding
authors.forename: M H
authors.initials: MH
authors.lastname: Foerster
mesh_terms: D001918:Brachytherapy; D002830:Choroid Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery*; D003131:Combined Modality Therapy; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007023:Hypotension, Controlled; D053208:Kaplan-Meier Estimate; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D012590:Sclera / Q000601:surgery; D014821:Vitrectomy